New Data Suggests T2 Biosystems’ T2Lyme Panel is More Accurate than Other Diagnostics for Identifying Borrelia Infections for Patients Suspected of Having Early Lyme Disease Genetics Investing
AMAG Pharmaceuticals Acquires Orphan Drug Candidate for Treatment of Severe Preeclampsia Pharmaceutical Investing
PreveCeutical Enters into Development Agreement with Asterion Cannabis Inc. to Develop Medicinal Cannabinoid Products Cannabis Investing News
Cellectar’s CLR 131 Receives FDA Orphan Drug Designation for the Treatment of Pediatric Osteosarcoma Biotech Investing
Fibrocell Awarded $1.4 Million FDA Orphan Grant for FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa Biotech Investing
VBI Vaccines Announces Second Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma Patients Biotech Investing
